REPARE THREUPATHICS
Repare Therapeutics Inc is a Canada-based precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations. Its approach integrates discoveries from several fields of cell biology including deoxyribonucleic acid (DNA) repair and synthetic lethality. Its SNIPRx platform combines a clustered regularly interspaced short palindromic repeats (CRISPR)-enabled gene editing target discovery method with protein crystallography, computational biology and clinical informatics. The Company’s pipeline products are RP-3500, Manchester and Pol0
Day Range Brought:25.29-26.23
EXACT SCIENCE CORP
Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer....
